ホーム › がん（全種類） › カリフォルニア州 › Mountain View
Mountain View、CAにおけるがん（全種類）の臨床試験
Mountain Viewとその周辺地域（約30マイル以内）の拠点で、がん（全種類）に関する40件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
被験者募集中第1相
- Stanford University School of Medicine, Stanford · 5マイル先
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
被験者募集中観察研究
- Stanford University, Palo Alto · 5マイル先
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
被験者募集中第3相
- Quetzal Site 5, Stanford · 5マイル先
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Sutter Palo Alto Medical Foundation: Palo Alto, Palo Alto · 5マイル先
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- Stanford Cancer Institute, Stanford · 5マイル先
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
被験者募集中第2/3相
- Stanford Cancer Center, Stanford · 5マイル先
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
被験者募集中第2相
- Stanford Cancer Institute, Stanford · 5マイル先
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
被験者募集中第1相
- Investigational Site Number: 403, Palo Alto · 5マイル先
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
被験者募集中第3相
- Research Site, Palo Alto · 5マイル先
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
被験者募集中観察研究
- Stanford, Palo Alto · 5マイル先
Prostate Active Surveillance Study
被験者募集中観察研究
- Stanford University, Stanford · 5マイル先
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
被験者募集中第1相
- Stanford University, Palo Alto · 5マイル先
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Lucile Packard Children's Hospital Stanford University, Palo Alto · 5マイル先
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Stanford Cancer Institute, Stanford University, Palo Alto · 5マイル先
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
被験者募集中第1相
- Stanford Cancer Center, Palo Alto · 5マイル先
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5マイル先
- 他1件
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
被験者募集中第2相
- 150, Palo Alto · 5マイル先
Evaluation of Grief Therapy Approaches for Bereaved Parents
被験者募集中
- Stanford University (Data Collection Only), Stanford · 5マイル先
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
被験者募集中第1/2相
- Stanford University - Stanford Cancer Institute, Stanford · 5マイル先
Childhood Cancer Survivor Study
被験者募集中観察研究健康なボランティア歓迎
- Stanford University School of Medicine, Stanford · 5マイル先
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto · 5マイル先
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- Stanford University, Stanford · 5マイル先
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
被験者募集中第1/2相
- Stanford Women's Cancer Center, Palo Alto · 5マイル先
Galleri® in the Medicare Population.
被験者募集中健康なボランティア歓迎
- Sutter Valley Hospitals PAMF Sutter, Palo Alto · 5マイル先
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
被験者募集中第1相
- GSK Investigational Site, Stanford · 5マイル先
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
被験者募集中第1/2相
- Lucille Packard Children's Hospital Stanford, Palo Alto · 5マイル先
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
被験者募集中第1/2相
- Stanford Cancer Institute, Stanford · 5マイル先
Impact of the Coronavirus (COVID-19) on Patients With Cancer
被験者募集中観察研究
- Stanford University School of Medicine, Stanford · 5マイル先
Suprachoroidal Administration in Subjects With Metastases to the Choroid
被験者募集中第2相
- Byers Eye Institute at Stanford University, Palo Alto · 5マイル先
Engagement of Veterans With Lung Cancer
被験者募集中
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5マイル先
Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making
被験者募集中健康なボランティア歓迎
- Stanford University, Palo Alto · 5マイル先
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
被験者募集中観察研究健康なボランティア歓迎
- Stanford University School of Medicine, Stanford · 5マイル先
Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
被験者募集中
- Stanford University, Palo Alto · 5マイル先
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
被験者募集中第1相
- Stanford Cancer Institute, Palo Alto · 5マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Stanford · 5マイル先
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
被験者募集中観察研究
- Stanford Cancer Center, Palo Alto · 5マイル先
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
被験者募集中観察研究健康なボランティア歓迎
- Exai Bio Inc., Palo Alto · 5マイル先
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- Stanford Cancer Institute, Palo Alto · 5マイル先
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
被験者募集中第1/2相
- Stanford University Cancer Institute, Stanford · 5マイル先
xPedite: A Study to Expedite DIPG and DMG Research
被験者募集中観察研究
- xCures, Inc., Los Altos · 2マイル先
他の都市におけるがん（全種類）の試験
- Houston, TX121件の研究
- New York City, NY109件の研究
- Boston, MA85件の研究
- Los Angeles, CA74件の研究
- Nashville, TN65件の研究
- Philadelphia, PA59件の研究
- Washington, DC58件の研究
- Durham, NC58件の研究
- Chicago, IL51件の研究
- Atlanta, GA49件の研究
- Seattle, WA49件の研究
- Arlington, VA48件の研究
Mountain Viewにおける他の研究
- 乳がん26件の研究
- 転移性癌25件の研究
- 非小細胞肺癌21件の研究
- 急性骨髄性白血病19件の研究
- 卵巣がん19件の研究
- 自閉スペクトラム症17件の研究
- 肺がん17件の研究
- 前立腺がん15件の研究
- 心不全15件の研究
- 自閉症13件の研究
- 急性リンパ性白血病13件の研究
- 大腸癌13件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。